Verastem Oncology has gained its first FDA approval, winning an accelerated nod for the combination treatment of avutometinib and defactinib for a rare form of ovarian cancer. With the commercial name of Avmapki Fakzynja Co-Pack, the combo becomes the first
read moreRoche is investing roughly $282 million to erect a new biomanufacturing hub in Shanghai. The plant, which will mark Roche’s second for branded medicines in the country, will mainly be used for domestic production of the eye med Vabysmo., More:
read moreThe addition of Imfinzi to standard-of-care Bacillus Calmette-Guérin (BCG) induction and maintenance therapy helped patients live longer without their disease coming back, AstraZeneca said on Friday. More: AstraZeneca opens the door to Imfinzi expansion with trial win in high-risk bladder
read more© 1994 - 2026 B.M. Pharmaceuticals